Hybrid Lipid/Polymer Nanoparticles to Tackle the Cystic Fibrosis Mucus Barrier in siRNA Delivery to the Lungs: Does PEGylation Make the Difference?

ACS Appl Mater Interfaces · 2022 · PMC8855343 · PMID 35107987

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

difference was apparentno p-value reported

As expected from hNPs/AM interaction studies, no significant difference was apparent between hNPs with or without PEI ( Figure 3 B).

also in 830 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.